demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 severe or critically
COVID-19 (hospitalized or not)
anti-interleukin-6
tocilizumab Hong Zhao

3 studies excluded by filtering options 2

5366 Rimland, 2020 2300excludednot a RCTrisk of bias not avaialble
5523 Toniati, 2020 2990excludednot a RCTrisk of bias not avaialble
5526 Price, 2020 2130excludednot a RCTrisk of bias not avaialble